Physician profile

Norman E Bennett

Cardiovascular Disease · Stuart, FL

NPI 1093776411

$751.20

in general payments reported to CMS, 2019-2025

16 companies · $187 in 2025

The $187 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$346.64

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novartis Pharmaceuticals Corporation $235.59 2020-2025
Abbott Laboratories $71.72 2021-2024 Amplatzer Amulet
Pfizer INC. $68.68 2020-2025
Heartflow, INC. $68.33 2025
Biosense Webster, INC. $64.55 2021
Astrazeneca Pharmaceuticals Lp $36.63 2019-2025
Boston Scientific Corporation $31.50 2022-2024 Watchman Flx
Janssen Pharmaceuticals, INC $28.48 2019-2023 Xarelto
Regeneron Healthcare Solutions, INC. $25.61 2019
Merck Sharp & Dohme LLC $23.69 2025 Winrevair
Medtronic, INC. $20.97 2025 Micra
Irhythm Technologies, INC. $18.21 2024 Zio Xt Patch, Zio Monitor
Sanofi-Aventis U.S. LLC $17.44 2021
Cvrx, INC. $14.23 2024 Barostim Neo System
Akcea Therapeutics, INC. $13.86 2021
Show all 16 companies
CompanyGeneral paymentsYearsTop products
E.R. Squibb & Sons, L.L.C. $11.71 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Norman E Bennett

$751.20

in general payments reported 2019-2025

Years
2019-2025
Top company
Novartis Pharmaceuticals Corporation
Context
The $187 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/276992/norman-e-bennett

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.